Loading clinical trials...
Loading clinical trials...
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Plecanatide (3.0 and 6.0 mg) in Patients With Chronic Idiopathic Constipation (The CIC3 Study)
Conditions
Interventions
Plecanatide
Placebo
+1 more
Locations
189
United States
Synergy Research Site
Birmingham, Alabama, United States
Synergy Research Site
Dothan, Alabama, United States
Synergy Research Site
Gulf Shores, Alabama, United States
Synergy Research Site
Huntsville, Alabama, United States
Synergy Research Site
Mobile, Alabama, United States
Synergy Research Site
Mesa, Arizona, United States
Start Date
November 1, 2013
Primary Completion Date
April 1, 2015
Completion Date
June 1, 2015
Last Updated
December 26, 2019
NCT04838522
NCT06736912
NCT03879239
NCT02819297
NCT03097861
NCT03551873
Lead Sponsor
Bausch Health Americas, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions